Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Revenue

Indo-Bangla Pharmaceuticals had revenue of 21.89M BDT in the quarter ending March 31, 2025, with 14.55% growth. This brings the company's revenue in the last twelve months to 91.10M, down -56.95% year-over-year. In the fiscal year ending June 30, 2024, Indo-Bangla Pharmaceuticals had annual revenue of 176.64M, down -52.83%.

• Revenue (ttm): 91.10M
• Revenue Growth: -56.95%
• P/S Ratio: 14.54
• Revenue / Employee: 599.33K
• Employees: 152
• Market Cap: 1.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	176.64M	-197.84M	-52.83%
Jun 30, 2023	374.48M	-110.20M	-22.74%
Jul 1, 2022	484.68M	-297.56M	-38.04%
Jul 1, 2021	782.24M	-83.86M	-9.68%
Jun 30, 2020	866.10M	125.38M	16.93%